ALKEM Alkem Laboratories Ltd Investments/Divestments Announcement 2023 - Investment Alkem Laboratories Ltd has entered into a co-development and license agreement with Biosergen AB for the development and commercialization of Biosergens novel polyene macrolide antifungal product BSG005 for severe invasive fungal disease..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Alkem Laboratories Ltd